Real-time enrollment status for this atopic dermatitis clinical trial
Current Status
Recruiting
Checked: October 12, 2026 at 3:21 PM UTC
| NCT Number | NCT07599813 |
| Recruiting Status | Recruiting |
| Condition | Atopic Dermatitis |
| Phase | PHASE2 |
| Target Enrollment | 280 participants |
| Active Locations | 33 sites in the US |
| Sponsor | Apollo Therapeutics Ltd |
| Last Updated on CT.gov | August 28, 2026 (Aug 28, 2026) |
As of October 12, 2026: Clinical trial NCT07599813 is currently recruiting participants. This phase2 study for atopic dermatitis is actively seeking new participants at 33 locations across the United States. The study is sponsored by Apollo Therapeutics Ltd. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07599813 is actively recruiting participants as of October 12, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 33 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07599813 was last updated Aug 28, 2026 (August 28, 2026). HelloStudys verifies this status automatically.